<DOC>
	<DOC>NCT00237172</DOC>
	<brief_summary>This is a extension study of CSTI571B1201 study</brief_summary>
	<brief_title>Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Patients who completed the CSTI571B1201 study Other protocoldefined inclusion / exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>GIST</keyword>
	<keyword>Imatinib</keyword>
	<keyword>STI571</keyword>
	<keyword>Gastrointestinal Stromal Tumors</keyword>
</DOC>